Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xulin Jiangu Granules for Postmenopausal Osteoporosis
NCT03563235Phase 1Unknown
- Sponsor
- Fujian Academy of Traditional Chinese Medicine
- Start
- Sep 2019
- Primary completion
- Sep 2021
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 1, randomised trial of Xulin Jiangu in postmenopausal osteoporosis (2 arms), sponsored by Fujian Academy of Traditional Chinese Medicine. Primary endpoint: Bone density at 6 months. Status: unknown.
02
Drugs
Xulin Jiangu
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT03563235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03563235.